The Latest Breaking News from Medicare

President Donald Trump said his executive order on drug prices would lower some prices in half or more. But the details are scant.

On election night, a triumphant Anthony Albanese took to the stage brandishing a Medicare card as a symbol of the nation’s commitment to public healthcare.

Volatility is back in a normal range, and the trend for the main equity indexes remains positive despite specific and general headwinds.

Justice department investigation into health insurance giant reported as company’s CEO says he will retire

UnitedHealth said it was not notified about the “supposed criminal investigation reported.”

The Dow Jones dropped Thursday, as Fed Chair Powell warned of volatile future inflation. UnitedHealth plunged on reports of a criminal probe.

UnitedHealth stock plunged on a Wall Street Journal report that it faces a criminal probe for Medicare fraud, the latest setback for the Dow giant.

Halozyme Therapeutics shares tumbled Tuesday on a new Medicare approach to price negotiations for drugs that use additive products.

Republicans in Congress intend to cut about US$880 billion in federal health care spending.

President Trump recently signed a wide-ranging executive order urging Congress to amend a crucial provision of a Biden-era law governing Medicare drug price negotiations, with the administration’s aim being to lower prices without kneecapping pharmaceutical industry investments in the research and development of innovative new drugs. The executive order marks…

President has directed Robert Kennedy to send price targets to industry, with slimming drugs thought to be included